Alliancebernstein L.P. Ironwood Pharmaceuticals Inc Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Alliancebernstein L.P. holds 163,070 shares of IRWD stock, worth $560,960. This represents 0.0% of its overall portfolio holdings.

Number of Shares

163,070

Previous 163,070 -0.0%

Holding current value

$560,960

Previous $1.06 Million 36.97%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$8.32 - $15.45 $32,123 - $59,652	-3,861 Reduced 2.31%	163,070 $1.42 Million
Q4 2023 Feb 14, 2024	BUY	$8.79 - $11.51 $51,860 - $67,909	5,900 Added 3.66%	166,931 $1.91 Million
Q1 2023 May 15, 2023	SELL	$10.37 - $12.56 $427,202 - $517,421	-41,196 Reduced 20.37%	161,031 $1.69 Million
Q4 2022 Feb 14, 2023	BUY	$9.9 - $12.43 $1,376 - $1,727	139 Added 0.07%	202,227 $2.51 Million
Q3 2022 Nov 15, 2022	SELL	$10.14 - $12.38 $265,789 - $324,504	-26,212 Reduced 11.48%	202,088 $2.09 Million
Q2 2022 Aug 15, 2022	SELL	$11.05 - $12.72 $54,377 - $62,595	-4,921 Reduced 2.11%	228,300 $2.63 Million
Q1 2022 May 13, 2022	SELL	$10.61 - $12.88 $88,063 - $106,904	-8,300 Reduced 3.44%	233,221 $2.93 Million
Q4 2021 Feb 14, 2022	SELL	$10.86 - $13.95 $633,181 - $813,340	-58,304 Reduced 19.45%	241,521 $2.82 Million
Q3 2021 Nov 10, 2021	BUY	$11.92 - $13.92 $649,687 - $758,695	54,504 Added 22.22%	299,825 $3.92 Million
Q2 2021 Jul 30, 2021	BUY	$10.16 - $13.11 $204,216 - $263,511	20,100 Added 8.92%	245,321 $3.16 Million
Q1 2021 May 06, 2021	SELL	$9.04 - $11.86 $744,082 - $976,196	-82,310 Reduced 26.76%	225,221 $2.52 Million
Q4 2020 Feb 08, 2021	BUY	$9.05 - $12.2 $392,860 - $529,602	43,410 Added 16.44%	307,531 $3.5 Million
Q3 2020 Nov 12, 2020	SELL	$8.99 - $10.74 $53,041 - $63,366	-5,900 Reduced 2.19%	264,121 $2.38 Million
Q2 2020 Aug 13, 2020	BUY	$9.14 - $11.97 $240,025 - $314,344	26,261 Added 10.77%	270,021 $2.79 Million
Q1 2020 May 14, 2020	BUY	$8.58 - $14.01 $41,184 - $67,248	4,800 Added 2.01%	243,760 $2.46 Million
Q2 2019 Aug 14, 2019	BUY	$9.8 - $12.89 $356,720 - $469,196	36,400 Added 17.97%	238,960 $2.61 Million
Q4 2017 Feb 13, 2018	SELL	$12.16 - $14.58 $37,696 - $45,198	-3,100 Reduced 1.51%	202,560 $3.04 Million
Q3 2017 Nov 13, 2017	BUY	$12.07 - $14.87 $2.48 Million - $3.06 Million	205,660	205,660 $3.24 Million

Others Institutions Holding IRWD

# of Institutions

238

Shares Held

162M

Call Options Held

11.2M

Put Options Held

9.1K

View Full List

About IRONWOOD PHARMACEUTICALS INC

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $527M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

More about IRWD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Ironwood Pharmaceuticals Inc Transaction History